The FDA approved new guidelines for a controversial Alzheimer's drug. Plus, there have been improvements in slowing down cancer-related deaths but health experts warn there is still more progress to be made. Also, drugmaker Pfizer plans to ask for approval of a third dose of its covid vaccine.